HilleVax clinical trials
Acquired by Ligand Pharmaceuticals Incorporated, Jul 14, 2026 · source ↗
The registry lists 4 studies whose lead sponsor is HilleVax. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 19, 2025.
Before and after it joined Ligand Pharmaceuticals Incorporated
- First submitted before HilleVax became part of Ligand Pharmaceuticals Incorporated
- 4
- First submitted after HilleVax became part of Ligand Pharmaceuticals Incorporated
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- HilleVax4 studies
Something wrong with this grouping? Tell us on the Ligand Pharmaceuticals Incorporated page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All Ligand Pharmaceuticals Incorporated studies →
- Serologic Assay Validation and Proficiency Testing of HIL-214 in AdultsCompletedNCT05972733Phase 2
Sponsor listed in the registry: HilleVax · First submitted before HilleVax became part of Ligand Pharmaceuticals Incorporated
- Efficacy and Safety of Two Doses of HIL-214 in ChildrenTerminatedNCT05281094Phase 2/3
Sponsor listed in the registry: HilleVax · First submitted before HilleVax became part of Ligand Pharmaceuticals Incorporated
- Safety and Immunogenicity of HIL-214 in Healthy Japanese InfantsCompletedNCT06007781Phase 1
Sponsor listed in the registry: HilleVax · First submitted before HilleVax became part of Ligand Pharmaceuticals Incorporated
- Safety and Immunogenicity of HIL-214 With Routine Pediatric VaccinesCompletedNCT05836012Phase 2/3
Sponsor listed in the registry: HilleVax · First submitted before HilleVax became part of Ligand Pharmaceuticals Incorporated